Status:
COMPLETED
Acupressure and Relaxation for Nausea Control
Lead Sponsor:
University of Rochester
Conditions:
Nausea
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
This study hypothesizes that patients receiving efficacy enhancing information about the acupressure bands will expect less treatment-related nausea, which will subsequently result in less treatment-r...
Detailed Description
This study hypothesizes that patients receiving efficacy enhancing information about the acupressure bands will expect less treatment-related nausea, which will subsequently result in less treatment-r...
Eligibility Criteria
Inclusion
- 1\) Have a diagnosis of breast cancer. 2) Be scheduled to receive a chemotherapy treatment containing doxorubicin (any dose) without concurrent radiotherapy or interferon. (Note: Chemotherapy agents in addition to doxorubicin may be given.) 3) Be 18 years of age or older. 3) Be chemotherapy naïve. 5) Be a female.
Exclusion
- 1\) Have clinical evidence of lymphedema, current bowel obstruction, or symptomatic brain metastases, as determined by their treating oncologist.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT00243269
Start Date
November 1 2005
End Date
January 1 2010
Last Update
June 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester James P. Wilmot Cancer Center
Rochester, New York, United States, 14642